Fingerprint
Dive into the research topics of 'Neratinib efficacy and circulating tumor DNA detection of HER2 mutations in HER2 nonamplified metastatic breast cancer'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Neratinib efficacy and circulating tumor DNA detection of HER2 mutations in HER2 nonamplified metastatic breast cancer
Cynthia X. Ma, Ron Bose, Feng Gao, Rachel A. Freedman, Melinda L. Telli, Gretchen Kimmick, Eric Winer, Michael Naughton, Matthew P. Goetz, Christy Russell, Debu Tripathy, Melody Cobleigh, Andres Forero, Timothy J. Pluard, Carey Anders, Polly Ann Niravath, Shana Thomas, Jill Anderson, Caroline Bumb, Kimberly C. Banks
- Section of Medical Oncology
- Institute of Clinical and Translational Sciences (ICTS)
- Siteman Cancer Center
- Roy and Diana Vagelos Division of Biology & Biomedical Sciences (DBBS)
- Division of Public Health Sciences
- Division of Anatomic and Molecular Pathology (AMP)
- Section of Molecular Oncology & Developmental Therapeutics
- DBBS - Molecular Cell Biology
- DBBS - Biochemistry, Biophysics, and Structural Biology
- DBBS - Cancer Biology
- Bursky Center for Human Immunology & Immunotherapy Programs (CHiiPs)
Research output: Contribution to journal › Article › peer-review
164
Scopus
citations